Q2 FY2026 · ended Jun 30, 2026 · Revenue $83.53M, +5.5% YoY · Filed Aug 7, 2026
Inogen, Inc. (INGN) files with the SEC under industry code 3842, Orthopedic, Prosthetic & Surgical Appliances & Supplies. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $83.5 million and a net loss of $3.9 million. Free cash flow was $2.2 million. As of Jun 30, 2026 it held $105.5 million in cash and investments and $15.8 million in total debt.
Company profile
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
- Listed as
- INGN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Beverly, MA
- SEC filer status
- Accelerated filer, Smaller reporting company
- SEC CIK
- 1294133
Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
- Intuitive Surgical Inc ISRG
- Edwards Lifesciences Corp EW
- STERIS plc STE
- Zimmer Biomet Holdings, Inc. ZBH
- Smith & Nephew PLC SNN
- Align Technology Inc ALGN
- MSA Safety Inc MSA
- Establishment Labs Holdings Inc. ESTA
All 29 Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $83.5M | $72.4M | $68.6M | $79.1M | $79.2M |
| Operating income | -$5.1M | -$9.3M | -$9.3M | -$7.1M | -$6.1M |
| Net income | -$3.9M | -$8.3M | -$7.1M | -$5.3M | -$4.2M |
| Diluted EPS | -$0.14 | -$0.30 | -$0.26 | -$0.20 | -$0.15 |
| Operating cash flow | $2.9M | -$6.7M | -$943,000 | $2.2M | $4.3M |
| Free cash flow | $2.2M | -$6.9M | -$1.9M | $1.6M | $3.7M |
| Total assets | $285.6M | $285.9M | $298.6M | $307.0M | $312.0M |
| Total liabilities | $110.7M | $103.0M | $106.4M | $109.8M | $112.5M |
| Stockholders' equity | $174.9M | $182.9M | $192.2M | $197.2M | $199.5M |
| Cash and investments | $105.5M | $110.2M | $119.6M | $123.2M | $122.4M |
| Total debt | $15.8M | $16.9M | $17.5M | $18.2M | $19.0M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Acquisition or sale of assets, Results of operations, Officer or director change, Regulation FD disclosure, Other events
|
Nov 5, 2026 | Oct 30, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Sep 30, 2026 | Sep 28, 2026 |
| 10-Q | Quarterly report | Aug 7, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 1, 2026 | Jul 1, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 11, 2026 | Jun 5, 2026 |
All 1001 Inogen, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.